Results 241 to 250 of about 91,806 (295)

Modulating Two‐Photon Absorption in a Pyrene‐Based MOF Series: An In‐Depth Investigation of Structure–Property Relationships

Advanced Functional Materials, EarlyView.
This study investigates H4TBAPy‐based metal–organic frameworks (MOFs) ‐ NU‐1000, NU‐901, SrTBAPy, and BaTBAPy ‐ for multiphoton absorption (MPA) performance. It observes topology‐dependent variations in the 2PA cross‐section, with BaTBAPy exhibiting the highest activity.
Simon N. Deger, Helmy Pacheco Hernandez, Yang Cui, Hongxing Hao, Vanessa Ramm, David C. Mayer, Khai‐Nghi Truong, Roland A. Fischer, Jürgen Hauer, Mariana Kozlowska, Alexander Pöthig   +10 more
wiley   +1 more source

Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap". [PDF]

Int J Health Policy Manag
Gleeson D, Scheibner J, Tenni BF, Townsend B, Nicol D.   +4 more
europepmc   +1 more source

Analysis of an intergenerational service-learning experience based on physical exercise in a community setting: a mixed-method study. [PDF]

Front Public Health
Alonso-Cortés Fradejas B, Lafuente-Ureta R, Calvo S, Fernández-Gorgojo M, Poveda-López JL, Jiménez-Sánchez C.   +5 more
europepmc   +1 more source

Patents legislation and international obligations: India [PDF]

Anjali Varma, Mahima Puri
core  

Building Lay Society Knowledge and Education for Health Technology Assessment and Policy Engagement: Case of CFTR Modulator Access in Brazil. [PDF]

Healthcare (Basel)
de Oliveira VSB, Amaral MB, Camargo M, Lopes-Pacheco M.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Compulsory Licenses in Patent Law

Munich Studies on Innovation and Competition, 2021
The chapter reviews the conditions for compulsory licenses for functional efficiency set in international law and the instruments’ adequacy to address the market failures that hinder follow-on innovation. Under the TRIPS Agreement, compulsory licenses (Art. 31) are a mechanism distinct from exceptions to patent protection (Art. 30).
openaire   +3 more sources

Compulsory Licenses For Medicines

Health Affairs, 2015
Ellen, 't Hoen, Jorge, Bermudez
openaire   +4 more sources

Compulsory Licensing of Patents

Pharmaceutical Patent Analyst, 2022
Compulsory licensing (CL) is a mechanism made by the government to provide balance between the monopoly right holders and the third person with public interest by ensuring the ease availability of the patented products at reasonable rate. This paper discusses the background criteria for getting CL in India as per the Indian Patent Act, 1970 starting ...
Narayanasamy Kumutha, Narayanasamy Amutha, Govindasamy S Venkatesh   +2 more
openaire   +2 more sources

Compulsory Licensing

2015
Practices across jurisdictions.- The operation of compulsory licensing regime.- Doctrinal discussions.
openaire   +1 more source